Abstract

There is public concern over the long term systemic health effects of metal released from hip replacement prostheses that use large-diameter metal-on-metal bearings. However, to date there has been no systematic study to determine which organs may be at risk, or the magnitude of any effect. We undertook a detailed cross-sectional health screen at a mean of 8 years after surgery in 35 asymptomatic patients who had previously received a metal-on-metal hip resurfacing (MoMHR) versus 35 individually age and sex matched asymptomatic patients who had received a conventional hip replacement. Total body bone mineral density was 5% higher (mean difference 0.05 g/cm2, P = 0.02) and bone turnover was 14% lower (TRAP 5b, mean difference −0.56IU/L, P = 0.006; osteocalcin, mean difference −3.08 ng/mL, P = 0.03) in the hip resurfacing versus conventional hip replacement group. Cardiac ejection fraction was 7% lower (mean absolute difference −5%, P = 0.04) and left ventricular end-diastolic diameter was 6% larger (mean difference 2.7 mm, P = 0.007) in the hip resurfacing group versus those patients who received a conventional hip replacement. The urinary fractional excretion of metal was low (cobalt 5%, chromium 1.5%) in patients with MoMHR, but creatinine clearance was normal. Diuretic prescription was associated with a 40% increase in the fractional excretion of chromium (mean difference 0.5%, P = 0.03). There was no evidence of difference in neuropsychological, renal tubular, hepatic or endocrine function between groups (P>0.05). Our findings of differences in bone and cardiac function between patient groups suggest that chronic exposure to low elevated metal concentrations in patients with well-functioning MoMHR prostheses may have systemic effects. Long-term epidemiological studies in patients with well-functioning metal on metal hip prostheses should include musculoskeletal and cardiac endpoints to quantitate the risk of clinical disease.

Highlights

  • There is public concern about the potential systemic health effects of metal exposure in patients who have received large diameter ($36 mm) metal-on-metal hip prostheses [1], there is little data available to quantitate which systems may be affected or the magnitude of any effect [2]

  • In the metal-on-metal hip resurfacing (MoMHR) group a further 15 patients were excluded for the following reasons: contra-indication to magnetic resonance imaging (MRI) (n = 3), inflammatory arthropathy or metabolic bone disease (n = 3), recent arthroplasty to other joints (n = 3), MoMHR revision (n = 1), use of calcium dietary supplements (n = 2), and current illness (n = 3)

  • In the total hip arthroplasty (THA) group 28 patients were excluded for the following reasons: complications or revision of the prosthesis (n = 10), failure of the matching criteria (n = 7), inflammatory arthropathy or metabolic bone disease (n = 3), glucocorticoid treatment (n = 3), contra-indication to MRI (n = 3), recent arthroplasty to other joints (n = 1) and subject withdrawal (n = 1)

Read more

Summary

Introduction

There is public concern about the potential systemic health effects of metal exposure in patients who have received large diameter ($36 mm) metal-on-metal hip prostheses [1], there is little data available to quantitate which systems may be affected or the magnitude of any effect [2]. The Food and Drug Administration (FDA) in the United States has recently (May 6th, 2012) instructed manufacturers of large diameter metal-on-metal hip prostheses to conduct cross-sectional studies covering the period from implantation out to 8 years after surgery in order to quantitate the adverse local and systemic effects of metal exposure from these devices (http://www.fda.gov/MedicalDevices/Safety/ AlertsandNotices/ucm335775.htm, accessed May 13th, 2013). We have recently shown that concentrations of cobalt and chromium equivalent to blood levels after MoMHR affect human bone cell viability and function invitro [13]. Linna et al [14], found cobalt workers exposed to a blood cobalt level of 2.5 mg/L over 9 years had echocardiographic evidence of altered left ventricular function versus unexposed controls

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call